University of Florida granted Radient's NuVax Therapeutics subsidiary a license to develop and commercialize immune-gene therapeutics technology for cancer

University of Florida

U.S. / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Radient Pharmaceuticals Corp.

U.S. / Medical Devices and Diagnostics

$26.8m on 01/21/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced